Aveo Capital Partners, LLC - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 51 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Aveo Capital Partners, LLC ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$13,000
-31.6%
16,7320.0%0.01%
-86.8%
Q2 2020$19,000
+171.4%
16,7320.0%0.04%
+1166.7%
Q1 2020$7,000
-12.5%
16,7320.0%0.00%0.0%
Q4 2019$8,000
-38.5%
16,7320.0%0.00%
-40.0%
Q3 2019$13,000
-62.9%
16,7320.0%0.01%
-66.7%
Q2 2019$35,000
-25.5%
16,7320.0%0.02%
-31.8%
Q1 2019$47,000
-7.8%
16,7320.0%0.02%
-12.0%
Q4 2018$51,000
-33.8%
16,7320.0%0.02%
-26.5%
Q3 2018$77,000
-28.0%
16,7320.0%0.03%
-27.7%
Q2 2018$107,000
-8.5%
16,7320.0%0.05%
-4.1%
Q1 2018$117,000
-58.1%
16,732
-37.4%
0.05%
-47.3%
Q4 2017$279,00026,7320.09%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,142,580$1,414,0001.91%
Game Plan Financial Advisors, LLC 44,550$17,0000.02%
Alyeska Investment Group, L.P. 743,398$332,0000.01%
Alyeska Investment Group, L.P. 500,000$223,0000.00%
Aveo Capital Partners, LLC 16,732$7,0000.00%
Squarepoint Ops LLC 67,258$30,0000.00%
MERCER GLOBAL ADVISORS INC /ADV 13,121$6,0000.00%
PANAGORA ASSET MANAGEMENT INC 2,261$1,0000.00%
GOLDMAN SACHS GROUP INC 51,297$23,0000.00%
BNP PARIBAS FINANCIAL MARKETS 154$69,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders